Tetratherix Ltd (TTX) - Total Liabilities
Based on the latest financial reports, Tetratherix Ltd (TTX) has total liabilities worth AU$13.68 Million AUD (≈ $9.68 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore TTX cash generation efficiency to assess how effectively this company generates cash.
Tetratherix Ltd - Total Liabilities Trend (2023–2025)
This chart illustrates how Tetratherix Ltd's total liabilities have evolved over time, based on quarterly financial data. See TTX net asset value for net asset value and shareholders' equity analysis.
Tetratherix Ltd Competitors by Total Liabilities
The table below lists competitors of Tetratherix Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Open Lending Corp
NASDAQ:LPRO
|
USA | $161.72 Million |
|
Nnit AS
CO:NNIT
|
Denmark | Dkr731.00 Million |
|
AVITA Medical Inc
F:51KB
|
Germany | €74.13 Million |
|
Hope Education Group Co. Ltd
F:HE1
|
Germany | €12.42 Billion |
|
Walchandnagar Industries Limited
NSE:WALCHANNAG
|
India | Rs5.17 Billion |
|
Gozde Girisim Sermayesi Yatirim Ortakligi AS
IS:GOZDE
|
Turkey | TL904.99 Million |
|
Robot Consulting Co., Ltd. ADS
NASDAQ:LAWR
|
USA | $965.36 Million |
Liability Composition Analysis (2023–2025)
This chart breaks down Tetratherix Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Tetratherix Ltd market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 12.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tetratherix Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tetratherix Ltd (2023–2025)
The table below shows the annual total liabilities of Tetratherix Ltd from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$4.59 Million ≈ $3.25 Million |
-43.95% |
| 2024-06-30 | AU$8.18 Million ≈ $5.79 Million |
+37.50% |
| 2023-06-30 | AU$5.95 Million ≈ $4.21 Million |
-- |
About Tetratherix Ltd
Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.